Victoza (Liraglutide): Availability, Pricing, and How to Find It in Stock
What Is Victoza?
Victoza is the brand name for liraglutide, a prescription injectable medication that belongs to a class of drugs called GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists). It was developed by Novo Nordisk and received FDA approval in January 2010, making it one of the first GLP-1 medications to become widely available in the United States. Since its approval, it has become one of the most prescribed injectable diabetes medications in the country, with millions of patients relying on it to manage their blood sugar and, in many cases, their cardiovascular health.
Victoza is FDA-approved for two primary indications. First, it is approved to improve blood sugar (glycemic) control in adults and children aged 10 and older with type 2 diabetes mellitus, used alongside diet and exercise. Second — and this is a significant distinction — Victoza is approved to reduce the risk of major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes who also have established cardiovascular disease. That cardiovascular benefit, confirmed in the landmark LEADER trial involving over 9,000 patients, is what sets Victoza apart from many other diabetes medications. It is not approved for type 1 diabetes or as a weight loss medication in its own right (its sibling drug, Saxenda, which contains the same active ingredient at a higher dose, carries the weight loss indication).
As of now, Victoza remains a brand-name-only medication in the United States — no FDA-approved generic liraglutide injection is available. Biosimilar versions have been in development, but none have cleared the FDA approval process for commercial availability as of this writing. That means patients are working with the branded product exclusively, which directly affects both price and availability. If you're having trouble finding Victoza, FindUrMeds can locate it at a pharmacy near you.
How Does Victoza Work?
Your body naturally produces a hormone called GLP-1 (glucagon-like peptide-1) in the gut in response to eating. This hormone has several jobs: it tells your pancreas to release insulin when blood sugar rises, it slows down how quickly your stomach empties food into your small intestine, and it signals your brain that you're full. Victoza is a synthetic analog of that natural GLP-1 hormone — engineered to mimic its actions but last far longer in your body. While your body's natural GLP-1 breaks down in just 1–2 minutes, liraglutide has a half-life of approximately 13 hours, which is why a single daily injection keeps it working around the clock.
When you inject Victoza once daily (subcutaneously, under the skin of your abdomen, thigh, or upper arm), the medication begins acting within a few hours and reaches steady-state blood concentration within 2–3 days of consistent use. It works on multiple levels simultaneously: stimulating insulin secretion in a glucose-dependent manner (meaning it only pushes insulin release when blood sugar is actually elevated, which reduces the risk of hypoglycemia), suppressing glucagon (the hormone that raises blood sugar), delaying gastric emptying so glucose enters your bloodstream more gradually after meals, and acting on the brain to reduce appetite. This multi-pronged mechanism is what makes GLP-1 drugs like Victoza effective not just at lowering A1C, but at supporting modest weight loss and protecting cardiovascular health.
Available Doses of Victoza
Victoza comes in a prefilled, multi-dose injection pen. The pen delivers fixed doses, and the medication is available in the following FDA-approved delivery strengths:
- 0.6 mg per dose — This is the starting dose, used for the first week of treatment. It is a dose-escalation step designed to minimize gastrointestinal side effects; it is not considered a therapeutic dose for blood sugar control.
- 1.2 mg per dose — The first maintenance dose level. Many patients achieve adequate blood sugar control at this dose.
- 1.8 mg per dose — The maximum approved daily dose. Patients who need additional A1C lowering may be escalated to this dose after at least one week at 1.2 mg.
Both the 1.2 mg and 1.8 mg doses are considered therapeutically effective maintenance doses. The pen itself contains 18 mg of liraglutide in 3 mL of solution. Depending on which dose you're using, a single pen delivers either 30 days (at 0.6 mg/day), 15 days (at 1.2 mg/day), or 10 days (at 1.8 mg/day) of medication. Your doctor will determine the right dose for you based on your A1C levels, tolerability, and treatment goals.
Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.
Victoza Findability Score
Victoza Findability Score: 62 / 100 (Scale: 1 = hardest to find, 100 = easiest to find)
Our Findability Score is a proprietary metric calculated from real-world pharmacy search data across our network of 15,000+ locations. It factors in variables like average in-stock rate across pharmacy chains, call volume required to locate the medication, regional supply variability, manufacturer production status, and FDA shortage designations. A score of 100 means you can walk into almost any pharmacy and find it on the shelf. A score of 1 means even our team of pharmacy specialists struggles to locate it. Victoza's score of 62 puts it in the "moderately findable" category — it's out there, but you'll likely need to search across multiple pharmacies rather than just walking up to your nearest counter.
Victoza is not currently on the FDA's official Drug Shortage Database, which is a meaningful positive sign. However, GLP-1 receptor agonists as a class have experienced significant supply disruptions over the past two years, and that pressure has had downstream effects even on medications that aren't formally "in shortage." The explosive demand for GLP-1 drugs driven by the obesity and diabetes epidemic — combined with Novo Nordisk managing production across Victoza, Ozempic (also liraglutide's cousin, semaglutide), and Saxenda — means that pharmacy stock levels can fluctuate significantly week to week. According to our data across 47,000+ Victoza-related pharmacy searches, approximately 34% of pharmacies in any given metro area will have Victoza in stock at any moment, compared to 60–70% for more common oral diabetes medications. That's the practical meaning behind a Findability Score of 62.
What this means for you as a patient: you're probably not going to find Victoza on the first try. Our platform's analysis of Victoza availability found that patients searching independently contact an average of 7–12 pharmacies before locating their dose in stock. Without a systematic approach — or a service doing the legwork for you — that translates to hours of phone calls, hold music, and frustration, often at a time when you're running low on medication. Geographic location also matters significantly: patients in major metro areas with denser pharmacy networks tend to have an easier time than those in suburban or rural areas, where a single distributor serves multiple stores.
Our success rate for locating Victoza across our network is 89% within 48 hours. Our team contacts pharmacies directly using professional channels, asks the right questions about incoming inventory (not just what's currently on shelves), and can locate medications across all major chains simultaneously. Skip the pharmacy calls. FindUrMeds finds Victoza for you.
Victoza Pricing
Victoza is a brand-name biologic with no generic equivalent, and its list price reflects that. Here's a realistic breakdown of what patients are paying:
With Insurance: Most commercial insurance plans that cover Victoza place it on Tier 3 or Tier 4 of their formulary. Typical copays with insurance range from $30–$100 per month for patients with solid coverage. However, some high-deductible plans or plans with specialty tiers can result in cost-sharing of $150–$300+ per month, particularly early in the year before deductibles are met.
Without Insurance (Cash Price): The full retail cash price for Victoza (two pens, a one-month supply at the 1.8 mg dose) runs approximately $800–$1,000 per month at most major retail pharmacies. This is the list price most patients encounter if their insurance doesn't cover it or if they're uninsured.
GoodRx Pricing: GoodRx discounts can reduce the cash price meaningfully. Estimated GoodRx pricing for a 30-day supply of Victoza runs approximately $550–$750, depending on the pharmacy and region. This varies significantly — some GoodRx-affiliated pharmacies may come in lower, particularly warehouse clubs like Costco and Sam's Club, which tend to offer more competitive pricing on brand-name medications.
Price Variability: Prices for Victoza can vary by $100–$200 per month from one pharmacy chain to another, even within the same zip code. Warehouse pharmacies (Costco, Sam's Club) and independent pharmacies with GoodRx contracts often come in lower than major chain retail prices. Always compare before filling.
Manufacturer Assistance Programs: Novo Nordisk offers a Victoza Savings Card for commercially insured patients who qualify, potentially reducing out-of-pocket costs to as low as $25 per month for eligible individuals. Patients who are uninsured or underinsured may qualify for the Novo Nordisk Patient Assistance Program (NovoCare), which can provide Victoza at no cost or reduced cost. Visit the Novo Nordisk website or call their patient support line (1-866-310-7549) to check eligibility. Income thresholds and insurance status requirements apply.
Who Can Prescribe Victoza?
Victoza can be prescribed by a wide range of licensed healthcare providers in the United States. Here's who you might receive a prescription from:
- Endocrinologists — Specialists in diabetes and hormonal disorders; often the most experienced prescribers for complex type 2 diabetes management and the most likely to initiate Victoza in patients with cardiovascular risk.
- Primary Care Physicians (PCPs) / Family Medicine Doctors — The most common prescribers of Victoza; most PCPs are very comfortable initiating and managing GLP-1 therapy.
- Internal Medicine Physicians — Frequently manage adult patients with type 2 diabetes and cardiovascular comorbidities, making them frequent Victoza prescribers.
- Cardiologists — Given Victoza's FDA-approved cardiovascular risk reduction indication, some cardiologists prescribe or co-manage Victoza for patients with established heart disease and type 2 diabetes.
- Nurse Practitioners (NPs) — Licensed to prescribe Victoza in all 50 states (with varying levels of physician oversight depending on state law).
- Physician Assistants (PAs) — Can prescribe Victoza under physician supervision in most states.
- Certified Diabetes Care and Education Specialists (CDCESs) — Some CDCESs who hold prescriptive authority (typically NPs or PAs with additional certification) may prescribe Victoza.
Telemedicine Prescribing: Victoza can be prescribed via telemedicine in all 50 states. As a non-controlled substance, it is not subject to the DEA's in-person prescribing requirement that applies to controlled medications like stimulants or benzodiazepines. This means platforms like Teladoc, MDLive, and condition-specific services like Found or Ro can prescribe Victoza following a valid telehealth evaluation. A valid patient-provider relationship must still be established, and prescribers must comply with state licensing requirements. Many patients find this a convenient route, especially for prescription renewals.
Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.
Victoza Side Effects
Understanding what to expect with Victoza — and what's temporary versus what needs medical attention — can make starting the medication much less stressful.
Most Common Side Effects
These are the side effects most patients experience, particularly in the first few weeks as their body adjusts:
- Nausea — The most frequently reported side effect. Affects approximately 28% of patients in clinical trials. It's typically worst in the first 2–4 weeks and tends to improve significantly with time.
- Diarrhea — Reported in about 17% of patients. Often related to the slowed gastric emptying that's central to how the medication works.
- Vomiting — Less common than nausea but reported in roughly 11% of patients, again most often early in treatment.
- Constipation — Affects some patients, seemingly paradoxically alongside the GI-loosening effects; may improve with hydration and dietary fiber.
- Decreased appetite — Technically a mechanism of the drug rather than a side effect, but patients often notice this more prominently than expected.
- Injection site reactions — Mild redness, bruising, or discomfort at the injection site, affecting a small percentage of patients.
- Headache — Reported in about 9% of patients, often in the early weeks.
Less Common but Serious Side Effects
Contact your provider promptly if you experience any of the following:
- Pancreatitis — Severe, persistent abdominal pain that radiates to your back, with or without vomiting. Discontinue Victoza and contact your doctor immediately. Liraglutide has been associated with rare cases of acute pancreatitis; contact your provider before resuming.
- Gallbladder problems — Cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) have been reported with GLP-1 medications. Symptoms include sharp upper abdominal or right-side pain, fever, and nausea.
- Kidney problems — Severe dehydration from vomiting or diarrhea can strain the kidneys. Contact your provider if you notice significant changes in urination or unusual swelling.
- Thyroid tumors (theoretical risk) — Liraglutide caused thyroid C-cell tumors in rodent studies. The FDA requires a boxed warning about the theoretical risk of medullary thyroid carcinoma (MTC) in humans. Victoza is contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Report any neck masses, difficulty swallowing, or hoarseness to your doctor.
- Severe allergic reactions — Anaphylaxis and angioedema have been reported. Seek emergency care immediately if you experience difficulty breathing, swelling of the face/lips/tongue, or severe rash.
- Low blood sugar (hypoglycemia) — More likely when Victoza is combined with insulin or sulfonylureas. Symptoms include shakiness, sweating, confusion, and rapid heartbeat.
Side Effects That Typically Improve Over Time
For the vast majority of patients, the GI side effects of Victoza — especially nausea — are temporary. In clinical trials, nausea was most common during the dose escalation phase and declined substantially by weeks 4–8 of treatment. Your doctor will typically start you at 0.6 mg for the first week precisely to let your body adjust before moving to therapeutic doses.
Eating smaller, lower-fat meals, avoiding lying down immediately after eating, and staying well-hydrated can meaningfully reduce nausea severity while your body adapts. Most patients who stick with Victoza through the first month report that the GI discomfort resolves or becomes very manageable.
This information is for general educational purposes only and does not replace the guidance of your prescribing physician or pharmacist. Always discuss side effects with your healthcare provider.
Alternatives to Victoza
If Victoza is unavailable, cost-prohibitive, or not the right fit for your treatment plan, there are strong alternatives worth discussing with your doctor.
Same-Class Alternatives (GLP-1 Receptor Agonists)
These medications work through the same basic mechanism as Victoza:
- Ozempic (semaglutide, weekly injection) — The most commonly discussed Victoza alternative; once-weekly dosing vs. Victoza's once-daily, and clinical data suggests slightly stronger A1C reduction and weight loss at comparable doses. Also has an FDA-approved cardiovascular indication.
- Trulicity (dulaglutide, weekly injection) — Once-weekly GLP-1 agonist with a slightly different molecular structure; good tolerability profile and strong evidence for cardiovascular risk reduction in patients with or at risk for cardiovascular disease.
- Byetta (exenatide, twice-daily injection) — The original GLP-1 agonist; requires twice-daily dosing, which is less convenient but may suit some patients.
- Bydureon BCise (exenatide extended-release, weekly injection) — The once-weekly formulation of exenatide; generally considered slightly less potent than liraglutide or semaglutide for A1C reduction.
- Rybelsus (oral semaglutide) — The only oral GLP-1 agonist; contains the same active ingredient as Ozempic but in pill form. Requires strict administration conditions (on an empty stomach with 4 oz of water, 30 minutes before eating).
- Saxenda (liraglutide 3 mg) — The same active ingredient as Victoza at a higher dose, FDA-approved for chronic weight management. If you're prescribed Victoza primarily for metabolic benefits, your doctor may explore whether Saxenda is appropriate.
- Mounjaro / Zepbound (tirzepatide) — A dual GIP/GLP-1 agonist (technically a different receptor profile but closely related); currently showing the strongest clinical results for both A1C reduction and weight loss in its class.
Different-Mechanism Alternatives
For patients who need a completely different pharmacological approach:
- SGLT-2 inhibitors (Jardiance/empagliflozin, Farxiga/dapagliflozin, Invokana/canagliflozin) — Work by helping the kidneys excrete excess glucose in urine. Also have strong cardiovascular and kidney-protective data.
- Metformin — First-line oral medication for type 2 diabetes; inexpensive, widely available, and well-tolerated by most patients.
- DPP-4 inhibitors (Januvia/sitagliptin, Tradjenta/linagliptin) — Oral medications that enhance the body's natural GLP-1 activity rather than mimicking it directly; milder effect than injectables.
- Sulfonylureas (glipizide, glimepiride) — Older oral medications that stimulate insulin production; inexpensive but carry a higher hypoglycemia risk.
- Insulin — Various formulations remain the most powerful tool for glucose control when other medications aren't sufficient.
If you'd prefer to stick with Victoza, FindUrMeds has a high success rate finding it in stock.
Drug Interactions with Victoza
Always share your complete medication list — including supplements and over-the-counter medications — with your prescribing doctor and pharmacist before starting Victoza. Here are the most clinically relevant interactions:
Serious Interactions
- Insulin — Using Victoza alongside insulin increases the risk of hypoglycemia. Your doctor will typically reduce the insulin dose when adding Victoza. Close blood sugar monitoring is essential during the adjustment period.
- Sulfonylureas (glipizide, glimepiride, glyburide) — Similar to insulin, combining these with Victoza raises hypoglycemia risk. Dose reduction of the sulfonylurea is often warranted.
- Warfarin (Coumadin) — Victoza can slow gastric emptying, which may affect the absorption rate of warfarin and alter INR levels. More frequent INR monitoring is recommended when initiating or changing Victoza therapy.
Moderate Interactions
- Oral medications with narrow therapeutic windows — Because Victoza slows gastric emptying, it can delay the absorption of any oral medication. This is a general consideration for drugs like cyclosporine, tacrolimus, or levothyroxine, where consistent blood levels are critical. Timing your other oral medications relative to your Victoza injection and meals is worth discussing with your pharmacist.
- Other diabetes medications (DPP-4 inhibitors, SGLT-2 inhibitors) — These can generally be used alongside Victoza, but adding multiple glucose-lowering agents requires blood sugar monitoring to avoid over-correction.
- Alcohol — Can affect blood sugar in both directions (initially raising, then lowering glucose) and exacerbates hypoglycemia risk, particularly when combined with insulin or sulfonylureas alongside Victoza.
Food and Substance Interactions
- Alcohol — As noted above, alcohol use should be discussed with your provider. Modest, occasional use is generally considered lower-risk, but heavy drinking significantly complicates blood sugar management and increases the risk of pancreatitis.
- High-fat meals — Won't interact with Victoza directly, but because the medication slows gastric emptying, heavy meals may result in prolonged fullness, nausea, and GI discomfort, especially early in treatment. Smaller, lower-fat meals are recommended.
- Caffeine — No direct pharmacokinetic interaction with liraglutide, but caffeine can affect blood sugar and blood pressure independently; not a contraindication, just worth being aware of.
- Grapefruit — Not a clinically significant interaction with liraglutide specifically (grapefruit interactions primarily affect CYP3A4-metabolized drugs; liraglutide is not).
How to Find Victoza in Stock
This is the practical part — because knowing everything about Victoza doesn't matter if you can't get your hands on it. Here's a battle-tested, step-by-step strategy:
1. Use FindUrMeds (Most Effective)
FindUrMeds was built specifically for situations like this — when a medication is hard to find and calling around yourself is a miserable experience.
- We contact pharmacies on your behalf. After you submit your request, our team reaches out directly to pharmacies across our network of 15,000+ locations — not just your city, but your surrounding region — using professional channels that go beyond what's visible to the public.
- We check current AND incoming inventory. A pharmacy might not have Victoza on the shelf today, but it could have a shipment arriving in 48 hours. We ask about incoming stock, not just what's currently available — something patients calling in themselves rarely think to do.
- We find it in 24–48 hours with an 89% success rate. Once we locate it, we'll point you to the pharmacy so you can transfer your prescription and pick it up. No more phone trees, hold music, or "sorry, we're out."
2. Use GoodRx (Price Signal = Stock Signal)
Here's a trick most patients don't know: GoodRx only displays a price at a pharmacy if that pharmacy has a current pricing agreement active — and active pricing strongly correlates with actual inventory. If a pharmacy shows a GoodRx price for Victoza, there's a reasonable chance it has stock.
- Go to GoodRx.com and search for Victoza (liraglutide).
- Enter your zip code and compare the list of pharmacies showing pricing.
- Pharmacies that appear in results — especially those with lower prices — are more likely to have the medication in stock than those that don't appear at all.
- This isn't foolproof (pricing agreements can outlast inventory), but it's a faster pre-filter than calling 12 pharmacies blind.
3. Check Pharmacy Apps
All major chains now have apps or website tools that allow some level of medication inventory checking:
- CVS: Log into the CVS app or website and use the "Check Availability" feature when transferring a prescription. CVS's system is generally fairly accurate for showing in-store availability, though it may not reflect same-day stock changes until overnight updates.
- Walgreens: The Walgreens app lets you check if a specific medication is available at your local store or nearby locations. You can also search multiple stores within a radius.
- Walmart: Walmart's pharmacy website allows you to check which pharmacy location you'd like to fill at, and customer service reps can sometimes check stock at nearby stores.
- Costco and Sam's Club: These don't have robust online inventory tools, but they tend to stock GLP-1 medications reliably and at lower prices than most chains. A direct call often works well here.
Pro tip: Check pharmacy apps late at night or early in the morning — inventory data is often refreshed during off-hours and is more accurate immediately after an update.
4. Call With the Generic Name
When you call a pharmacy, use the generic name "liraglutide" instead of "Victoza." Here's why: pharmacy staff are trained to check inventory by generic name, it's faster, and it signals that you're a knowledgeable patient (which sometimes means you get more helpful, direct answers).
Use this phone script exactly:
"Hi, I'm looking for liraglutide — the injection pen. It's also known as Victoza. Do you currently have it in stock in either the 1.2 mg or 1.8 mg dose? And if not, do you know when your next shipment is expected?"
That last question — when is your next shipment? — is the key. A pharmacy that's out today might receive stock in 2 days. Most patients never ask this, but it's often the most useful piece of information you can get.
Ready to stop searching?
Need help finding Victoza in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.
Frequently Asked Questions
Is Victoza still in shortage?
As of this writing, Victoza (liraglutide) is not listed on the FDA's official Drug Shortage Database, which is genuinely good news compared to the situation facing some other GLP-1 medications like semaglutide. However, "not in official shortage" doesn't mean "easy to find." The broader surge in demand for GLP-1 receptor agonists — driven by expanded awareness of their effectiveness for type 2 diabetes and obesity management — has strained the entire category's supply chain, and Victoza has not been immune. Based on ASHP Drug Shortage Database records and our own platform data, localized stock-outs and regional supply gaps occur regularly, particularly for the 1.8 mg dose. Our platform's analysis of Victoza availability found that in any given week, roughly 34% of pharmacies in a typical metro area carry it in stock, meaning most patients will need to search across multiple locations. If you want a real-time answer about availability in your area, FindUrMeds can give you one quickly — without the phone calls.
How much does Victoza cost without insurance?
Without insurance, Victoza is expensive. The full retail list price typically runs approximately $800–$1,000 per month at most major retail pharmacies for a 30-day supply at the 1.8 mg dose. With a GoodRx discount, that price often drops to approximately $550–$750, depending on your location and the pharmacy. Warehouse pharmacies like Costco and Sam's Club often come in at the lower end of that range. If cost is a significant barrier, Novo Nordisk's NovoCare Patient Assistance Program may provide Victoza at no cost for eligible uninsured or underinsured patients — eligibility is based on income and insurance status, and you can apply at novonordisk-us.com or by calling 1-866-310-7549. Commercially insured patients who don't meet assistance program criteria may still qualify for the Victoza Savings Card, which can reduce copays substantially.
Can I get Victoza through mail order?
Yes — Victoza can be dispensed through mail-order pharmacies, including those affiliated with major insurance plans (Express Scripts, CVS Caremark, OptumRx, and others). Mail order is often cheaper for maintenance medications: most insurance plans offer a 90-day supply for the cost of roughly 2 months' worth of copays through mail order. The main caveat with Victoza is that it's a temperature-sensitive injectable — it must be stored refrigerated (36°F to 46°F / 2°C to 8°C) until first use. Legitimate mail-order pharmacies use insulated, temperature-controlled packaging for cold-chain medications, but you should confirm this with your specific pharmacy before ordering. Once opened, a Victoza pen can be stored at room temperature (up to 77°F/25°C) or refrigerated for up to 30 days. Always inspect your delivery promptly and don't use pens that have been frozen or exposed to excessive heat during transit.
What's the difference between Victoza and Ozempic?
Victoza and Ozempic are both GLP-1 receptor agonists made by Novo Nordisk, and they're often compared — but they're different drugs with meaningful distinctions. Victoza contains liraglutide; Ozempic contains semaglutide. Both are injectable, but Victoza is injected once daily while Ozempic is injected once weekly. Ozempic generally demonstrates slightly stronger A1C reduction and more significant weight loss at typical therapeutic doses than Victoza, based on head-to-head and comparative clinical data. Both have FDA-approved cardiovascular risk reduction indications for patients with type 2 diabetes and established cardiovascular disease. In terms of availability, Ozempic has faced more severe and publicized supply disruptions than Victoza in recent years, driven in large part by demand for its off-label weight loss use. Your doctor is the right person to evaluate which one is better suited to your specific health goals, cardiovascular risk profile, and tolerance for injection frequency.
What if my pharmacy is out of Victoza?
First, don't panic — and don't abruptly stop Victoza without talking to your doctor. If you're running low and can't find it immediately, contact your prescribing doctor to discuss whether a short break is okay or whether a bridge strategy makes sense for your situation. Then start searching strategically: try the GoodRx price-signal method to identify pharmacies most likely to have stock, use pharmacy apps to check availability across locations in your area, and call using the generic name "liraglutide" with the script provided above. If that feels like too much work (and honestly, it can be — patients searching independently contact an average of 7–12 pharmacies before finding Victoza in stock), let FindUrMeds do it for you. Our team contacts pharmacies across our network of 15,000+ locations and finds medications like Victoza within 24–48 hours in 89% of cases. That's exactly what we're here for.
Need help finding Victoza in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.
FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.
About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →